Skip to main content
. Author manuscript; available in PMC: 2017 Oct 18.
Published in final edited form as: JACC Basic Transl Sci. 2017 Apr 24;2(2):212–226. doi: 10.1016/j.jacbts.2016.11.008

Figure 4. Structures of biomaterials for MI and PAD applications.

Figure 4

Biomaterial structures dictate important parameters including degradation and controlled release of therapeutics. The architecture, shown by scanning electron micrographs, varies among hydrogels, such as (A) keratin, (B) porcine-derived skeletal muscle ECM, (C) porcine-derived pericardial ECM, (D) collagen, (E) alginate, or (F) fibrin. Additionally, hydrogel architecture differs from particles like (G) poly(lactic-co-glycolic acid) microparticles or (H) acetalated dextran microparticles. Reproduced with permission from (49,55,61,88,91–93):

Freeman I, Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009;30:2122–31.

Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomaterialia 2012;8:3695–3703.

DeQuach JA, Lin JE, Cam C et al. Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model. Eur Cell Mater 2012;23:400–12; discussion 412.

Suarez S, Grover GN, Braden RL, Christman KL, Almutairi A. Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI. Biomacromolecules 2013;14:3927–35.

Losi P, Briganti E, Magera A et al. Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors. Biomaterials 2010;31:5336–5344.

Formiga FR, Pelacho B, Garbayo E et al. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. J Control Release 2014;173:132–9.

Shen D, Wang X, Zhang L et al. The amelioration of cardiac dysfunction after myocardial infarction by the injection of keratin biomaterials derived from human hair. Biomaterials 2011;32:9290–9299.